/other/Spermosens_AB_publ-logo.jpg?Expires=1749969199&Signature=G1EA9bMlZ3JbT36cJd~039nG1S62Jl~3lT4Tq0XdoNeyqFCMlareRGRAY~1aWMQPNC9UmXrJmH7EQ89k-k2TIw6UnoSZNH4UoMxZY6ZeKaqIPnNoC0baomgqVS-8IoarSmqguN4DYGD-~1pYLqoX4OOnbO~7V9RHHcky4JYoPPVLoccc4D2j~f3MVCKbKWQWHtMkZD3Pvm3gReHtijpw3dnRIOW5m2k0J5H-SRsi3KUzRtXDyBw1qUXRF8gWJlAjOyhGxJ4N0R2-el7MkVxdIDPTK2YTJ2LTf~~nQSBEY0QgXh2UEk-9hMfWZojaRpTBP00gL9B1lNF5QUcajixf1A__&Key-Pair-Id=K6QMJA61RGOXQ)
Spermosens AB (publ)
SPERM | SPGR
Overview
Corporate Details
- ISIN(s):
- SE0015346424 (+6 more)
- LEI:
- 549300OM4P4VB7T8RN09
- Country:
- Sweden
- Address:
- Medicon Village, 223 81 Lund
- Website:
- https://spermosens.com/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Spermosens are active in medical technology. The company specializes in the development of medical devices. The product portfolio is broad and includes products for male infertility and individually tailored fertility treatments. Research and development is conducted via its own technological platform that analyzes sperm quality, which is further used for medical data and potential fertilization. The largest operations are in the Nordic market.
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Date | Filing | Language | Size | Actions |
---|---|---|---|---|
No filings match the current criteria. |
Insider Transactions
Date | Insider Name | Position | Type | Shares | Value |
---|---|---|---|---|---|
No insider transactions recorded for this company. |
Peer Companies
Company | Country | Ticker | View | |
---|---|---|---|---|
![]() |
1NKEMIA | Spain | IKM | |
![]() |
2cureX AB | Sweden | 2CUREX | |
![]() |
4SC AG | Germany | VSC | |
![]() |
Abera Bioscience AB | Sweden | ABERA | |
![]() |
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
![]() |
AB Science | France | AB | |
![]() |
Acticor Biotech | France | ALACT | |
![]() |
Active Biotech | Sweden | ACTI | |
![]() |
AcuCort AB | Sweden | ACUC |